- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02483949
Healthy Eating and Active Living for Diabetes - Gestational Diabetes Mellitus (HEALD-GDM)
Study Overview
Status
Intervention / Treatment
Detailed Description
Study Objective:
To examine the effectiveness of a group-based lifestyle modification program followed by peer-led telephone counselling for type 2 diabetes (T2D) and cardiovascular disease risk reduction. The lifestyle modification program will support daily ambulatory activity and low glycemic index food intake among women with previous GDM.
Methods:
To achieve the study objective, the HEALD-GDM lifestyle modification program already proven effective for adults with T2D among women with previous GDM within 12 months postpartum will be evaluated. Women will take part in either the HEALD-GDM program (intervention) or in usual care (control). To evaluate the effectiveness of HEALD-GDM, a randomized, two-arm, before and after study design is proposed. Potentially eligible participants will be recruited from Diabetes in Pregnancy Clinics in Calgary and Edmonton, Alberta. Following identification of eligible participants, the investigators will randomize 100 participants to either the HEALD-GDM program or to usual care control (i.e., 50 per group). A Canadian Society of Exercise Physiology certified instructor (Exercise Specialist) trained in HEALD-GDM delivery will lead the program. Group-based classes will be held at community recreational centres in Calgary and Edmonton (one site each) in months one and four of the 24-week HEALD-GDM program. Theory-guided peer-led telephone counselling will supplement the program. HEALD-GDM focuses broadly on T2D prevention through lifestyle modification and will be based on a proven effective pedometer-based active living behaviour.
The primary outcome will be change in objectively measured moderate and vigorous physical activity at assessment appointments (baseline and 24 weeks). Secondary outcomes include: 1) body mass, 2) glycemic control (hemoglobin A1c), 3) musculoskeletal and cardiorespiratory fitness, 4) dietary intake, 5) metabolic biomarkers, 6) health-related quality of life (HRQL), social-cognitive mediators and 7) mental health.
Significance:
Evidence for appropriate lifestyle modification programs for this high-risk population is lacking. This study will serve to inform best practices for diabetes and cardiovascular disease risk reduction through known modifiable risk reduction targets such as healthy eating and active living.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Alberta
-
Athabasca, Alberta, Canada, T9S 3A3
- Athabasca University
-
Edmonton, Alberta, Canada
- Alliance for Canadian Health Outcomes Research in Diabetes
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- laboratory confirmed previous and recent (within last 12 months) gestational diabetes mellitus • informed consent
Exclusion Criteria:
- unable to provide informed consent or unwilling to participate in the study
- unable to read, understand and converse in English
- contraindications based on the Canadian Society for Exercise Physiology Physical Activity Readiness Questionnaire Plus (PAR-Q+)
- currently enrolled in other diabetes-related research studies
- pregnant or planning another pregnancy in the next 12 months (any participants becoming pregnant at any point during the study will only contribute data prior to their pregnancy date)
- hemoglobin A1c >6.5% or clinical suspicion of type 1 or type 2 diabetes
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
No Intervention: Control
|
|
Experimental: Intervention
Lifestyle intervention with peer-counseling follow-up
|
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change from baseline to 6 months of moderate and vigorous physical activity (walking).
Time Frame: 6 months
|
Accelerometer derived MVPA
|
6 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change from baseline to 6 months in Low Glycemic Index foods.
Time Frame: 6 months
|
Low glycemic index food intake will be assessed using three-day food records.
|
6 months
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Steven T. Johnson, PhD, Athabasca University
Publications and helpful links
Helpful Links
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- HEALD-GDM
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Diabetes Mellitus Gestational Previous Pregnancy
-
IRCCS Burlo GarofoloCompletedGestational Diabetes | Gestational Diabetes Mellitus | Pregnancy-Induced Diabetes | Diabetes Mellitus, Gestational | Diabetes, Pregnancy InducedIsrael, Italy, Netherlands, Slovenia, Sri Lanka
-
Assistance Publique - Hôpitaux de ParisActive, not recruitingGestational Diabetes Mellitus in PregnancyFrance
-
i-Health, Inc.CompletedGestational Diabetes Mellitus in PregnancyGermany
-
The Danish Center for Strategic Research on Type...Odense University HospitalCompletedGestational Diabetes Mellitus in PregnancyDenmark
-
Services Institute of Medical Sciences, PakistanCompletedGestational Diabetes Mellitus in PregnancyPakistan
-
Danone Asia Pacific Holdings Pte, Ltd.Nutricia ResearchTerminatedGestational Diabetes Mellitus in PregnancySingapore
-
Unity Health TorontoRecruitingGestational Diabetes Mellitus in PregnancyCanada
-
Women's Hospital School Of Medicine Zhejiang UniversityActive, not recruitingGestational Diabetes Mellitus in PregnancyChina
-
Peking Union Medical College HospitalUnknownGestational Diabetes Mellitus in PregnancyChina
-
Gulsum UysalCompletedGestational Diabetes Mellitus in PregnancyTurkey
Clinical Trials on Healthy Eating and Active Living for Diabetes - Gestational Diabetes Mellitus
-
Wolfson Medical CenterNot yet recruitingPolyhydramnios
-
Hospices Civils de LyonCompletedOral Glucose Tolerance Test and Post Partum Diagnosis of Diabetes Mellitus, Type 2 (DT2 Post-Partum)Gestational DiabetesFrance
-
University of MauritiusCompleted
-
HealthPartners InstituteAbbott Diabetes CareCompletedGlucose Variability | CGM | NonDiabetesUnited States
-
HealthPartners InstituteAbbott Diabetes CareCompletedDiabetes | Glucose Variability | CGMUnited States
-
Sohag UniversityCompletedRenal Disorder Associated With Type II Diabetes MellitusEgypt
-
Cukurova UniversityRecruitingQuality of Life | Motivational Interviewing | Self Efficacy | Gestational Diabetes MellitusTurkey
-
Singapore Institute for Clinical SciencesNational University Polyclinics, Singapore; National University of SingaporeCompletedHealthy | Diabetes, Gestational | Gestational Diabetes Mellitus in PregnancySingapore
-
University of Sao PauloUnknown
-
Washington University School of MedicineActive, not recruiting